Vir Bio Identifies 2 Antibodies That Might Stop Coronavirus
Vir Biotechnology (NASDAQ: VIR) announced Wednesday morning that its researchers have identified two monoclonal antibodies (mAbs) that bind to the SARS-CoV-2 spike protein found on the surface of the coronavirus that the World Health Organization officially named COVID-19 this week.
The disease, first identified in Wuhan, China, has killed more than 1,100 people and infected more than 45,000 worldwide.
"We are pleased that, using the same platform that was used to isolate mAb114, which has proven to be active against Ebola, we have quickly identified antibodies with potential biological activity against SARS-CoV-2," said Chief Scientific Officer Herbert "Skip" Virgin. "We are working as rapidly as possible and look forward to sharing more information as we have it."
Source Fool.com
